A naturally occurring soluble isoform of murine Fas generated by alternative splicing

doi:10.1084/jem.182.5.1395

This Article

Full Text (PDF, 1056K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Hughes, D. P.

Articles by Crispe, I. N.

Search for Related Content

PubMed

PubMed Citation

Articles by Hughes, D. P.

Articles by Crispe, I. N.

Pubmed/NCBI databases

Gene	GEO Profiles
HomoloGene	Protein
UniGene

Social Bookmarking

What's this?

ARTICLES

A naturally occurring soluble isoform of murine Fas generated by alternative splicing

DP Hughes and IN Crispe
Immunobiology Section, Yale University Medical School, New Haven, Connecticut 06510, USA.

We report a soluble isoform of mouse Fas, which is generated by alternative splicing of Fas mRNA to a newly identified exon located between exons 2 and 3 of the previously published Fas sequence. This splicing event creates a novel Fas transcript, Fas beta, with the potential to encode a truncated form of the extracellular domain, termed Fas B. In vitro, P815 mastocytoma cells transfected with Fas B become resistant to Fas ligand-induced apoptosis, and the resistance is mediated by a secreted product of the transfected cells. In vivo, Fas beta mRNA expression is correlated inversely with apoptosis among subsets of intrahepatic T lymphocytes, a cell population in which activation-induced T cell apoptosis occurs. We propose that Fas B is a new cytokine that acts physiologically to limit apoptosis induced by Fas ligand.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Bamias, G., Mishina, M., Nyce, M., Ross, W. G., Kollias, G., Rivera-Nieves, J., Pizarro, T. T., Cominelli, F. (2006). From the Cover: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. USA 103: 8441-8446 [Abstract] [Full Text]
Levine, S. J. (2004). Mechanisms of Soluble Cytokine Receptor Generation. J. Immunol. 173: 5343-5348 [Abstract] [Full Text]
Pinti, M., Biswas, P., Troiano, L., Nasi, M., Ferraresi, R., Mussini, C., Vecchiet, J., Esposito, R., Paganelli, R., Cossarizza, A. (2003). Different Sensitivity to Apoptosis in Cells of Monocytic or Lymphocytic Origin Chronically Infected with Human Immunodeficiency Virus Type-1. Exp. Biol. Med. 228: 1346-1354 [Abstract] [Full Text]
Boursalian, T. E., Fink, P. J. (2003). Mutation in Fas Ligand Impairs Maturation of Thymocytes Bearing Moderate Affinity T Cell Receptors. JEM 198: 349-360 [Abstract] [Full Text]
Vermijlen, D., Luo, D., Froelich, C. J, Medema, J. P., Kummer, J. A., Willems, E., Braet, F., Wisse, E. (2002). Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J. Leukoc. Biol. 72: 668-676 [Abstract] [Full Text]
Wang, X., Kumanogoh, A., Watanabe, C., Shi, W., Yoshida, K., Kikutani, H. (2001). Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 97: 3498-3504 [Abstract] [Full Text]
Sica, G. L., Zhu, G., Tamada, K., Liu, D., Ni, J., Chen, L. (2001). RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-{kappa}B. Blood 97: 2702-2707 [Abstract] [Full Text]
Felderhoff-Mueser, U, Herold, R, Hochhaus, F, Koehne, P, Ring-Mrozik, E, Obladen, M, Bührer, C (2001). Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus. Arch. Dis. Child. 84: 369-372 [Abstract] [Full Text]
BUGEON, L., DALLMAN, M. J. (2000). Costimulation of T Cells. Am. J. Respir. Crit. Care Med. 162: S164-168 [Abstract] [Full Text]
Riccioli, A., Starace, D., D'Alessio, A., Starace, G., Padula, F., De Cesaris, P., Filippini, A., Ziparo, E. (2000). TNF-{alpha} and IFN-{gamma} Regulate Expression and Function of the Fas System in the Seminiferous Epithelium. J. Immunol. 165: 743-749 [Abstract] [Full Text]
Hingorani, R., Bi, B., Dao, T., Bae, Y., Matsuzawa, A., Crispe, I. N. (2000). CD95/Fas Signaling in T Lymphocytes Induces the Cell Cycle Control Protein p21cip-1/WAF-1, Which Promotes Apoptosis. J. Immunol. 164: 4032-4036 [Abstract] [Full Text]
Jenkins, M., Keir, M., McCune, J. M. (2000). A Membrane-bound Fas Decoy Receptor Expressed by Human Thymocytes. J. Biol. Chem. 275: 7988-7993 [Abstract] [Full Text]
Ayroldi, E., D'Adamio, F., Zollo, O., Agostini, M., Moraca, R., Cannarile, L., Migliorati, G., Delfino, D. V., Riccardi, C. (1999). Cloning and Expression of a Short Fas Ligand: A New Alternatively Spliced Product of the Mouse Fas Ligand Gene. Blood 94: 3456-3467 [Abstract] [Full Text]
Hartmann, A. M., Nayler, O., Schwaiger, F. W., Obermeier, A., Stamm, S. (1999). The Interaction and Colocalization of Sam68 with the Splicing-associated Factor YT521-B in Nuclear Dots Is Regulated by the Src Family Kinase p59fyn. Mol. Biol. Cell 10: 3909-3926 [Abstract] [Full Text]
Muschen, M., Warskulat, U., Perniok, A., Even, J., Moers, C., Kismet, B., Temizkan, N., Simon, D., Schneider, M., Haussinger, D. (1999). Involvement of Soluble CD95 in Churg-Strauss Syndrome. Am. J. Pathol. 155: 915-925 [Abstract] [Full Text]
Jenkins, M., Keir, M., McCune, J. M. (1999). Fas Is Expressed Early in Human Thymocyte Development But Does Not Transmit an Apoptotic Signal. J. Immunol. 163: 1195-1204 [Abstract] [Full Text]
Zheng, T. S., Schlosser, S. F., Dao, T., Hingorani, R., Crispe, I. N., Boyer, J. L., Flavell, R. A. (1998). Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc. Natl. Acad. Sci. USA 95: 13618-13623 [Abstract] [Full Text]
Caricchio, R., Reap, E. A., Cohen, P. L. (1998). Fas/Fas Ligand Interactions Are Involved in Ultraviolet-B-Induced Human Lymphocyte Apoptosis. J. Immunol. 161: 241-251 [Abstract] [Full Text]
Albanese, J., Meterissian, S., Kontogiannea, M., Dubreuil, C., Hand, A., Sorba, S., Dainiak, N. (1998). Biologically Active Fas Antigen and Its Cognate Ligand Are Expressed on Plasma Membrane-Derived Extracellular Vesicles. Blood 91: 3862-3874 [Abstract] [Full Text]
Stokes, T. A., Rymaszewski, M., Arscott, P. L., Wang, S. H., Bretz, J. D., Bartron, J., Baker Jr.;, J. R., Fiedler, P., Schaetzlein, C. E., Eibel;, H., Papoff, G., Stassi, G., De Maria, R., Giordano, C., Galluzzo, A., Bagnasco, M., Ruberti, G., Testi;, R. (1998). Constitutive Expression of FasL in Thyrocytes. Science 279: 2015-2015 [Full Text]
Landowski, T. H., Qu, N., Buyuksal, I., Painter, J. S., Dalton, W. S. (1997). Mutations in the Fas Antigen in Patients With Multiple Myeloma. Blood 90: 4266-4270 [Abstract] [Full Text]